NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 914 filers reported holding NOVARTIS A G in Q4 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $863,000 | +0.8% | 10,063 | +1.2% | 0.40% | +4.1% |
| Q3 2018 | $856,000 | +12.8% | 9,940 | -1.1% | 0.39% | +19.5% |
| Q2 2018 | $759,000 | -13.8% | 10,048 | -7.7% | 0.32% | -21.4% |
| Q1 2018 | $881,000 | -5.9% | 10,892 | -2.3% | 0.41% | -7.0% |
| Q4 2017 | $936,000 | -2.1% | 11,146 | +0.1% | 0.44% | -4.3% |
| Q3 2017 | $956,000 | +5.5% | 11,131 | +2.5% | 0.46% | +3.1% |
| Q2 2017 | $906,000 | +6.8% | 10,859 | -4.9% | 0.45% | +8.5% |
| Q1 2017 | $848,000 | +47.7% | 11,424 | +84.3% | 0.41% | +25.2% |
| Q4 2014 | $574,000 | -0.7% | 6,198 | +0.9% | 0.33% | -1.8% |
| Q3 2014 | $578,000 | +9.5% | 6,140 | +5.2% | 0.34% | -1.2% |
| Q2 2014 | $528,000 | -28.1% | 5,834 | -32.4% | 0.34% | -31.3% |
| Q1 2014 | $734,000 | -54.1% | 8,630 | -56.7% | 0.50% | -52.1% |
| Q4 2013 | $1,600,000 | +11.8% | 19,909 | +6.7% | 1.03% | -1.5% |
| Q3 2013 | $1,431,000 | +12.4% | 18,651 | +3.6% | 1.05% | +8.4% |
| Q2 2013 | $1,273,000 | – | 17,998 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |